Journal of Nephrology & Therapeutics

4^th International Conference on Nephrology & Therapeutics

September 14-16, 2015 Baltimore, USA

Scientific Tracks Abstracts

• Use of statins in chronic kidney disease

  Varun Agrawal

  PDF HTML

• Creating an oligopoly in the treatment of end stage renal disease and the subsequent impact on home hemodialysis therapies

  John D Sullivan

  PDF HTML

• Vascular access placement in patients with incident CKD stage 4 and 5 attending an inner city nephrology clinic: A cohort study and survey of providers

  Narender Goel1,2

  PDF HTML

• Current guidelines and trends for kidney stone management; advancing care of renal stone disease in the United States – Optimizing surgical outcomes and focusing on prevention

  Julio G Davalos

  PDF HTML

• Renal replacement therapy in the ICU: Time to end the controversy

  H Sudarshan Ballal

  PDF HTML

• Development of new drugs or OMICS-diagnostics of treatment failure

  Dmytro D Ivanov

  PDF HTML

• What is the risk of chronic kidney disease after acute kidney injury in the neonatal period?

  Alison Kent

  PDF HTML

• UTI in Children: A changing paradigm

  Rajendra Bhimma

  PDF HTML

• Online-HDF: The superior quality of treatment

  Thomas Ryzlewicz

  PDF HTML

• Importance of venous congestion and perfusion pressure in acute kidney injury and the cardiorenal syndrome

  Ihab Wahba

  PDF HTML

• Is there a better outcome for posterior urethral valve (PUV) presenting antenatally? A unicentre experience in 81 children

  Satish Kumar Kolar Venkatesh

  PDF HTML

• Cardiovascular abnormalities in patients of chronic kidney disease on hemodialysis - A study from tribal areas of Chhattisgarh presenting to a tertiary care hospital

  Punit Gupta and G B Gupta

  PDF HTML

• Workshop on Onconephrology

  Ayman Aly Seddik

  PDF HTML

• Cardiovascular risk factors evolution during 6 months intradialytic aerobic cycling program in hemodialysis patients: Hypertension, hyperlipidemia, hemoglobin stability and cardiovascular morbidity in hemodialysis patien

  Rouchon-Isnard Myriam and Coutard Celine

  PDF HTML

• Glycated hemoglobin in the screening and diagnosis of renal post-transplantation diabetes

  Ana Laura Pimentel

  PDF HTML

• Dyslipidemia in diabetic nephropathy

  Nasir Yunus Fulara

  PDF HTML

• Renoprotective effects of citral on accelerated and severe lupus nephritis mice by inhibiting activation signal of NLRP3 inflammasome and enhancing Nrf2 activation

  Shuk-Man Ka

  PDF HTML

• Chronic kidney disease and psoriasis in gestation

  Amna Wahab2, Musleh Uddin Kalar1, Nabila Kalar3, Mariam A Zaaibi4, Fizza Hassan2, Kissa Batool2, Anum Jamal2, Nazish Iqbal2, Tuba Moiz2, Sidra Jamal5, Farah Asghar2, Musleh Uddin Kalar1 and Meytar Eliya Osakwe6

  PDF HTML

• CD4+CD25+ Treg cells may be useful for the treatment of IgAN

  Hongdong Huang

  PDF HTML

• MAKE-D i.e Mobile Artificial Kidney Extended Devices

  Punit Gupta

  PDF HTML

• Extracellular superoxide dismutase with heparin binding domain retards the progression of streptozotocin-induced diabetic nephropathy

  Chia-Wen Kuo1,2

  PDF HTML

• Challenges in management of diabetic ketoacidosis in haemodialysis patients, case presentation and review of literature, towards management guidelines

  Ayman Aly Seddik, Alaaeldin Mohammed Bashir, Amna Khalifa Alhadary, Fakhryia AlAlway, Hind Hassan Alnour and Mohammed Jaffer Railey

  PDF HTML

• Early diagnosis and treatment of breast cancer in Japanese kidney transplant recipients: A single center experience

  Jun-ya Kaimori1, Taigo Kato1, Yoichi Kakuta1, Kazuaki Yamanaka1, Masayoshi Okumi2, Toyofumi Abe1, Ryoichi Imamura1, Naotsugu Ichimaru1, Shiro Takahara and Norio Nonomura1

  PDF HTML

• Role of angiotensin converting enzymes inhibitor and angiotensin receptor blockers in Type-1 diabetic nephropathy

  Nasim Musa

  PDF HTML

• Renal dysfunction and metabolic syndrome: The chicken or the egg?

  Elena Rampanelli1,2, Peter Ochodnicky1, Evelyn Orso2, Sandrine Florquin1,3, Gerd Schmitz2 and Jaklien C Leemans1

  PDF HTML

• Nephrolithiasis in pregnancy

  Niharika Mehta

  PDF HTML

• Arginine vasopressin: What else does it do?

  Michael F Michelis

  PDF HTML

• Optimal serum potassium, calcium and magnesium in the coronary care unit

  Chayakrit Krittanawong

  PDF HTML

• Accompanying mild hypothermia significantly improved the prognosis of septic mice than artificial mild hypothermia

  Qilian Xie, Xiao-Shuang Li, Li Liu, Yu-lian Jin, Fei-Fei Luo, Lin Li and Jingfeng Zhu

  PDF HTML

• Elevated tumor marker CA125: Interpretations in renal disease

  Sohini Sengupta Neogi and L M Srivastava

  PDF HTML

• Magnesium (Mg) deficiency worsens and Mg replacement protects against cisplatin-induced kidney injury in non-tumor and tumor-bearing mice

  Christine N Metz

  PDF HTML

• Persuade of prevention of renal failure in an imperfect world, is it possible in the 21st century?

  Bhaskar Reddy

  PDF HTML

• Efficacy of dietary interventions in end stage renal disease patients

  Chaudhary Muhammad Junaid Nazar

  PDF HTML

• How we can protect the kidney about the side effects of drugs

  Manuela Stoicescu

  PDF HTML

• Post kidney transplantation Diabetes

  Mahamane Kalil Maiga

  PDF HTML

• End-stage renal disease in north region of Oman: Epidemiology, incidence and aetiology

  Ruqiya Al-Za’abi, Elizabeth Tolmiea and Ann Marie Rice

  PDF HTML

• Challenge for treatment: Bilateral renal artery aneurysms

  Nikola M Fatic

  PDF HTML

• CCN3-based therapy: A first-in-class preventative and treatment to block and reverse renal and other organ fibrosis complicating diabetes

  Bruce L Riser1,2

  PDF HTML

• Prophylactic ozone administration reduces renal ischemia-reperfusion injury in the rat

  Ozkan Onal

  PDF HTML